Alvotech ALVO
NASDAQ ALVO
$5.21 +0.02 (+0.38%)
As of: Sep 9, 2026 · 3:59 PM EDT

Alvotech (ALVO) Net Shares Issued and Repurchased (2024 - 2025)

Alvotech's (ALVO) quarterly Net Shares Issued and Repurchased came in at $312021.4 billion in Q4 2025, up 3.38% on a YoY basis from $301805.7 billion in Q4 2024, and up 3.38% quarter-over-quarter from $301805.7 billion in Q4 2024.

Analysis

Alvotech (ALVO) Net Shares Issued and Repurchased (2024 - 2025) Analysis & Trends

Alvotech (ALVO) has reported Net Shares Issued and Repurchased for 2 consecutive years, with $312021.4 billion the latest figure, recorded in Q4 2025.

  • For the quarter ending Q4 2025, Net Shares Issued and Repurchased rose 3.38% year-over-year to $312021.4 billion; the trailing twelve-month figure through Dec 2025 stood at $312021.4 billion (up 3.38% YoY), and the FY2025 full-year result was $312021.4 billion, up 3.38% from the prior year.
  • Net Shares Issued and Repurchased grew to $312021.4 billion in Q4 2025 per ALVO's latest filing, from $301805.7 billion in the prior quarter.
  • Across five years, Net Shares Issued and Repurchased topped out at $312021.4 billion in Q4 2025 and bottomed at $301805.7 billion in Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Shares Issued and Repurchased (Qtr)
1 Teva Pharmaceutical Industries 42.84 Bn 39.19 Bn 2.15 Bn -
2 Viatris 19.13 Bn 18.24 Bn 1.46 Bn -
3 Dr Reddys Laboratories 9.91 Bn 9.74 Bn 396.53 Mn -
4 Amneal Pharmaceuticals 5.51 Bn 5.38 Bn 334.51 Mn -
5 Bausch Health Companies 2.30 Bn 464.50 Mn 2.10 Bn -
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn -
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn -
8 Amphastar Pharmaceuticals 1.00 Bn 714.13 Mn 93.47 Mn -
9 Fennec Pharmaceuticals 402.10 Mn 360.85 Mn 17.15 Mn 31,000.00
10 RedHill Biopharma 178.35 Mn 178.35 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 312,021.38 Bn
Dec 31, 2024 301,805.68 Bn